๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Urinary hexosaminidase in patients with lung carcinoma

โœ Scribed by M. G. Brattain; P. M. Kimball; J. R. Durant; T. G. Pretlow II; D. Smith; J. Carpenter; M. Marks


Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
485 KB
Volume
44
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


The specific activity of urinary hexosaminidase was determined in 58 patients with various histological types of lung carcinoma, Compared to an apparently healthy control population, 32/35 patients with widely disseminated disease showed elevated values and 18/23 patients with disease confined to the chest had normal hexosaminidase values. Detailed studies of 18 patients indicated that declining hexosaminidase values were associated with effective therapy, rising values generally accompanied progressive disease.

Cancer 442267-2272, 1979.

B IOCHEMICAL AND IMMUNOCHEMICAL TU- MOR MARKERS are of potential importance in the diagnosis and-management of cancers. The assay of human chorionic gonadotropin (HCG), for example, is essential to the proper clinical management of choriocarcinoma in females' and both the measurement of HCG and alphafetoprotein are invaluable in the treatment of testicular germ cell n e o p l a s m ~. ~* ~. ~ Although some advances have been made in the development of useful markers for other carcinomas, satisfactory laboratory adjuncts are generally lacking for lung carcinomas." These are becoming important because of the recent developments of effective therapeutic regimens for lung cancer (particularly oat cell) and the difficulty in assessing objective responses in these patients.

Recent investigations have indicated that the detection of elevated levels of substances in the urine of cancer patients, such as poly-aminesI4 or the lysosomal enzyme, arylsul-fatase13 are of potential use as tumor markers. Other studies have suggested that Nacetyl hexosaminidase (either total activity or that of particular isozymes) may be elevated in various animal and human turn or^.^^^^"s ~1 1 ~1 5 Hexosaminidase degrades molecules


๐Ÿ“œ SIMILAR VOLUMES


Second primary cancers in patients with
โœ Fabio Levi; Lalao Randimbison; Van-Cong Te; Carlo La Vecchia ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 66 KB ๐Ÿ‘ 1 views

There are only limited population-based data available regarding the risk of developing a second cancer after a diagnosis of lung carcinoma. ## METHODS. Data collected from the Cancer Registry of the Swiss Canton of Vaud (comprised of approximately 600,000 inhabitants) were used to estimate the i

Survival of patients with carcinoma in s
โœ Liang Cheng; John C. Cheville; Roxann M. Neumann; Bradley C. Leibovich; Kathleen ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 175 KB ๐Ÿ‘ 2 views

## BACKGROUND. To the authors' knowledge, the long term follow-up of patients with carcinoma in situ of the urinary bladder is limited. ## METHODS. The authors studied 138 patients diagnosed with urothelial carcinoma in situ of the bladder at the Mayo Clinic between 1972-1979. All the histologi

Lung carcinoma in 36 patients with human
โœ Umberto Tirelli; Michele Spina; Simonetta Sandri; Diego Serraino; Carlo Gobitti; ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB ๐Ÿ‘ 1 views

The current study describes the clinicopathologic characteristics of 36 patients with lung carcinoma and human immunodeficiency virus (HIV) infection observed within the Italian Cooperative Group on AIDS and Tumors (GICAT). ## METHODS. Patients with lung carcinoma and HIV infection collected by th